We planned to complete an audit cycle. Review of guidelines and legislations relevant to medical documentation was conducted to establish a gold standard, which resulted in creation of a questionnaire as audit tool. The answers to the questions were among Yes/No/Not applicable. Ninety case notes were audited against the questionnaire by an auditor and areas of deficiencies were identified. To address those deficiencies using the above-mentioned standards, a Medical Assessment Proforma was constructed and implemented for a prospective trial of 3 months. As a secondary measure and to facilitate clinical handover among all disciplines, a section for ISBAR handover was added to the front page of the proforma. The staff got educated regarding the new proforma. At the end of the trial period, using the original audit tool, another audit was conducted on 90 patients to assess thoroughness of documentation on the new proforma. The results were analysed using a Chi-squared test; the significant level was taken as P < 0.05.
OutcomesThe implementation of the admission proforma led to statistically significant improvement in details of the clerking in the following areas: None of the items were more accurately documented prior to implementation of the proforma. There was a 100% compliance with documenting ISBAR handover section on the front cover of the proforma which is expected to improve structured clinical handover.
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Conclusion:
Utilizing a standard medical admission proforma significantly improved overall documentation on admission to the acute medical unit. This is expected to enhance the quality of patient care, decrease medico-legal risks to medical patients, generate more accurate funding for medical units and decrease the risk arising from coding errors. Between hospital comparisons of baseline co-morbidities revealed significant difference in hypertension (P = 0.014) only. Sevelamer hydrochloride was most commonly used at RBWH at 41%, followed by calcium carbonate (32%) and aluminium hydroxide (22%). In contrast, both Northlakes and Redcliffe had similar phosphate binder use with calcium carbonate being most popular (36% and 58% respectively), followed by sevelamer hydrochloride (33% and 15% respectively) and aluminium hydroxide (8% and 14% respectively). Forty-two percent of RBWH patients, 45% of Redcliffe patients and 58% of Northlakes patients were taking two or more classes of phosphate binders. There were no statistically significant differences across the three kidney health services in relation to total pill burden (P = 0.17), weekly phosphate binder cost (P = 0.13), or serum calcium (P = 0.35), serum phosphate (P = 0.61) and serum PTH (P = 1.00). Comparison of weekly phosphate binder cost between the three sites revealed no significant difference (P = 0.12) with RBWH $41.58 (1.89-84.58), Redcliffe $5.32 (1.89-46.52) and Northlakes $44.87 (5.20-87.52).
References
Conclusions:
No appreciable differences in the pill burden and phosphate binder cost per week were associated with biochemical outcomes between the RBWH, Northlakes and Redcliffe kidney health service. Several studies have recently emerged regarding the lack of efficacy and survival benefit of phosphate binders in patients undergoing centre-based haemodialysis. This study reinforces ongoing concerns regarding the minimal biochemical and economic improvement associated with phosphate binder use in this group of dialysis patients. Future studies should compare the cost and pill burden of phosphate binders in other Australian centres and ascertain whether any biochemical and economic changes occur in patients undergoing haemodialysis in the home environment.
RHABDOMYOLYSIS: REVIEW OF CASES OVER A DECADE AT A REGIONAL TEACHING HOSPITAL
Choy K, Holgate S, Delmenico L, McVeigh M and Friedman D Department of General Medicine, University Hospital Geelong, Barwon Health, Geelong, Victoria, Australia Introduction: Rhabdomyolysis is defined as a clinical and laboratory syndrome as a consequence of skeletal muscle injury resulting in the release of muscular cell constituents, predominantly myoglobin into the extracellular fluid and the circulation. There is a varied spectrum of severity of rhabdomyolysis ranging from a subclinical increase in creatine kinase (CK) levels to interstitial and muscle cell oedema, and pigment-induced acute kidney injury (AKI). Causes of rhabdomyolysis can be divided into traumatic, including crush injuries, long-term confinement to the same position and strenuous exercise, and non-traumatic, such as infections, drugs, myopathies and hyperthermia. University Hospital Geelong is the largest regional tertiary hospital in Victoria, Australia. We reviewed ICD-10-AM coding data for diagnoses of rhabdomyolysis over a 10-year period at our institution.
Methods: Utilising relevant ICD-10 codes, a retrospective review of medical records from May 2006 to May 2016 of patients coded with a diagnosis of rhabdomyolysis was undertaken. An episode of rhabdomyolysis was defined as acute elevation of serum CK value greater than five times the upper limit of normal (>1000 U/L). Data extracted included: patient 
